Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PegIFN Add-on in HBeAg-negative CHB (QUANTI-B)
NCT02743182Completed
- Start
- Jan 2015
- Primary completion
- Oct 2018
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
Randomised, open-label trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB) (2 arms). Primary endpoint: Number of patients with HBsAg loss. Started Jan 2015; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02743182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02743182.